Cardiologic Hospital Haut l'évêque
Pessac, 33604, France
NCT Number: NCT01260402
Biventricular pacing is a validated treatment for patients suffering from heart failure resistant to medical treatment. However, up to 30% of the patients are non responsive to this strategy using the coronary sinus approach to pace the Left Ventricle (LV).
It has been demonstrated that the magnitude of the improvement was highly dependant on the LV pacing site. The coronary sinus approach rarely offers more than 1 or 2 potential pacing sites. Resynchronisation using a transeptal approach to pace the left ventricle on the cardiology has been shown feasible on small series. We therefore would like to compare these two approached in a randomised prospective study to confirm the hypotheses that endocardial LV pacing by offering multiple choices for the pacing sites reduces the number of non responders and is associated with greater hemodynamic benefit when compared to the conventional coronary sinus approach.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Pessac, 33604, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cardiac resynchronization with one in the right ventricle and one in the left ventricle via a transeptal puncture.
Devices used for procedure : Medtronic C304 or 6227DEF, Nykanen RF Wire, RADI PressureWire
Cardiac resynchronization with one in the right ventricle and one in the left ventricle via the coronary sinus.
Devices used for procedure : RADI PressureWire, routine catheters chosen by operator
Time frame: Visit 3 : implantation day, during pacing procedure
The primary outcome will be the acute hemodynamic response of the randomized pacing modality (endocardial vs epicardial Left Ventricle pacing) as judged by the highest gain in dP/dt max
Time frame: Visit 3 : implantation day, end of pacing procedure
Time frame: Visit 3 : implantation day, end of pacing procedure
Time frame: Visit 3 : implantation day, end of pacing procedure
Time frame: Visit 4 : within 7 days after pacing procedure
Time frame: within 7 days after pacing procedure
Time frame: within 7 days after pacing procedure
Time frame: within 7 days after pacing procedure
Time frame: within 7 days after pacing procedure
Time frame: within 7 days after pacing procedure
Time frame: within 7 days after pacing procedure
Time frame: within 7 days after pacing procedure
Time frame: Visit 6 : 6-months after pacing procedure
Time frame: 6-months after pacing procedure
Time frame: 6-months after pacing procedure
Time frame: 6-months after pacing procedure
Time frame: 6-months after pacing procedure
Time frame: 6-months after pacing procedure
Time frame: 6-months after pacing procedure
Time frame: 6-months after pacing procedure
Time frame: 6-months after pacing procedure
Time frame: 6-months after pacing procedure
Time frame: 6-months after pacing procedure
Time frame: 6-months after pacing procedure
University Hospital, Bordeaux
Other
Acronym: EPI-ENDO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01270646
Cardiomegaly, Cardiomyopathies
Pessac, France
View Trial DetailsNCT00001313
Angina Pectoris, Aortic Stenosis, Subvalvular
Bethesda, Maryland, United States
View Trial DetailsNCT02579655
Brain Diseases, Cardiovascular Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT06890208
Anxiety Disorders, Arrhythmias, Cardiac
Hamburg, Germany
View Trial Details